A. Laupacis, “Evidence and Values: Requirements for Public Reimbursement of Drugs for Rare Diseases- A Case Study in Oncology- Reply”, J Popl Ther Clin Pharmacol, vol. 16, no. 2, Dec. 2018, Accessed: Sep. 17, 2026. [Online]. Available: https://jptcp.com/index.php/jptcp/article/view/557